Arcturus Therapeutics Ltd (NASDAQ:ARCT)

6.03
Delayed Data
As of May 21
 -0.06 / -0.99%
Today’s Change
4.78
Today|||52-Week Range
15.19
-24.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization8.0K31.0K51.0K61.0K
 
 
 
 
 
 
Operating ExpensesGross Income-8.0K-31.0K-51.0K-61.0K
 
 
 
 
 
General Expenses10.3M32.0M18.7M25.1M
 
 
 
 
 
Other Operating Expenses0.001.1M935.0K0.00
 
 
 
Research And Development7.1M25.1M13.5M18.4M
 
 
 
 
 
Total Operating Expenses10.3M33.1M19.7M25.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.3M-33.1M-19.7M-25.2M
 
 
 
 
 
Interest Expense On Debt203.0K10.0K7.0K19.0K
 
 
 
 
 
Other Expenses-16.0K0.00-31.0K-142.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.5M-32.9M-19.4M-24.5M
 
 
 
 
 
Income Taxes-61.0K-17.0K-51.0K-73.0K
 
 
 
 
 
Net Income-10.5M-32.8M-19.4M-24.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M2.0M3.1M3.9M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M2.0M3.1M3.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.28-$16.80-$6.30-$6.23
 
 
 
 
 
EPS Diluted-$7.28-$16.80-$6.30-$6.23